Latest News
-
Aster Clinics UAE to expand network to more than 100 facilities by 2030
The network plans to scale diabetes care using a “clinic within a clinic” approach, enabling patients to access integrated and convenient services for chronic disease management.
-
Mayo Clinic expands Middle East footprint with opening of Riyadh Representative Office
The new office strengthens Mayo Clinic’s presence in the Middle East and provides a direct link between patients in Saudi Arabia and its medical campuses in the US and UK.
-
FDA approves Outlook Therapeutics’ Lytenava as first ophthalmic Bevacizumab for wet AMD
Lytenava contains bevacizumab, an anti-vascular endothelial growth factor (anti-VEGF) antibody that inhibits the growth of abnormal blood vessels that can damage the retina.
-
Merck signs early voluntary licenses for investigational monthly HIV prevention pill
The agreements are nonexclusive and cover Aspen Pharmacare, Quality Chemical Industries and UCL Kenya in sub-Saharan Africa, as well as Aurobindo, Cipla, Emcure and Viatris in India.
-
Cleveland Clinic Abu Dhabi implants first wireless heart sensor for remote heart failure monitoring
The minimally invasive technology enables doctors to monitor patients remotely and identify changes in their condition before symptoms become severe.
-
EHS introduces twice-yearly schizophrenia treatment BYANNLI at Al Amal Psychiatric Hospital
Schizophrenia is a chronic and complex mental health disorder that can significantly affect patients, their families and caregivers when inadequately managed.
-
Oxford begins human trials for the experimental Bundibugyo Ebola vaccine
The experimental vaccine was developed by scientists at the University of Oxford using the same vaccine technology employed in the Oxford-AstraZeneca COVID-19 vaccine.
-
Malaria Journal Study reveals key drivers for improving child malaria prevention in South Sudan
Since South Sudan introduced SMC in 2022, the programme has helped protect children aged three to 59 months from malaria during peak transmission periods.
-
Kyowa Kirin extends Crysvita EU orphan market exclusivity to February 2030
The approval follows a positive recommendation issued in April 2026 by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP).
-
Milly Glass SEZ to build Africa’s first dedicated pharmaceutical bottle factory in Mombasa
Milly Glass SEZ director Mohamed Rashid said the company expects to break ground by the end of August 2026 and begin producing amber pharmaceutical bottles by July 2027.